Silence Therapeutics (SLN) Return on Sales: 2021-2025
Historic Return on Sales for Silence Therapeutics (SLN) over the last 5 years, with Sep 2025 value amounting to -2.50%.
- Silence Therapeutics' Return on Sales rose 120.00% to -2.50% in Q3 2025 from the same period last year, while for Sep 2025 it was -2.50%, marking a year-over-year increase of 120.00%. This contributed to the annual value of -1.05% for FY2024, which is 67.00% up from last year.
- As of Q3 2025, Silence Therapeutics' Return on Sales stood at -2.50%, which was up 14.21% from -2.91% recorded in Q2 2025.
- In the past 5 years, Silence Therapeutics' Return on Sales ranged from a high of -0.01% in Q4 2021 and a low of -3.70% during Q3 2024.
- Over the past 3 years, Silence Therapeutics' median Return on Sales value was -2.39% (recorded in 2024), while the average stood at -2.31%.
- Per our database at Business Quant, Silence Therapeutics' Return on Sales slumped by 288bps in 2022 and then spiked by 125bps in 2024.
- Silence Therapeutics' Return on Sales (Quarterly) stood at -0.01% in 2021, then tumbled by 266bps to -2.67% in 2022, then skyrocketed by 38bps to -2.29% in 2023, then skyrocketed by 125bps to -1.05% in 2024, then spiked by 120bps to -2.50% in 2025.
- Its Return on Sales was -2.50% in Q3 2025, compared to -2.91% in Q2 2025 and -2.58% in Q1 2025.